Younger patients starting off with a higher-than-recommended dose elevated their risk of self-harm compared with those who started at lower doses, according to a study from the JAMA Internal Medicine based on 162,000 patients ages 10 to 64. Nearly 18% of patients in the study started on doses …

READ FULL ARTICLE Curated publisher From Time